Tokyo, Japan

Masaru Ohbayashi

This inventor holds 7 USPTO granted patents. Top assignees: Bristol-Myers Company, Bristol-Myers Squibb Compnay. Active years: 1989-1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masaru Ohbayashi. Retrieved from https://idiyas.com/inventor/masaru-ohbayashi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1989-1991

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Masaru Ohbayashi: Innovator in Antibiotic Development

Introduction

Masaru Ohbayashi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of antibiotic research, holding a total of 7 patents. His work focuses on developing novel antibiotics that possess unique therapeutic properties.

Latest Patents

One of Ohbayashi's latest innovations is the BU-4146T antibiotic. This novel antibiotic is produced by the fermentation of the Streptomyces amphibiosporus strain R310-104 (ATCC-53964). The BU-4146T antibiotic exhibits both antifungal and antitumor activity, showcasing its potential in treating various infections and diseases.

Career Highlights

Throughout his career, Masaru Ohbayashi has worked with notable companies, including Bristol-Myers Company and Bristol-Myers Squibb Company. His experience in these organizations has allowed him to advance his research and contribute to the development of effective antibiotics.

Collaborations

Ohbayashi has collaborated with esteemed colleagues in his field, including Masataka Konishi and Koji Tomita. These partnerships have fostered innovation and have been instrumental in his research endeavors.

Conclusion

Masaru Ohbayashi's contributions to antibiotic development are noteworthy, particularly with his invention of the BU-4146T antibiotic. His work continues to impact the field of medicine and offers hope for new treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…